ethidium bromide has been researched along with etoposide in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Estévez-Braun, A; Jiménez-Alonso, S; Machín, F; Orellana, HC; Pérez-Sacau, E; Ravelo, AG | 1 |
| Dong, G; Guo, Z; Miao, Z; Sheng, C; Wang, S; Yao, J; Zhang, W; Zhang, Y | 1 |
| Banerjee, UC; Baviskar, AT; Das, D; Guchhait, SK; Kandekar, S; Kashyap, M; Kundu, CN; Mohapatra, P; Preet, R; Satapathy, SR; Siddharth, S | 1 |
| Chen, W; Ma, Y; Qiu, J; Shen, Y; Zhao, B | 1 |
| Chang, IH; Jun, KY; Kwon, Y; Lee, E; Lee, ES; Na, Y; Park, SE | 1 |
| Chen, SB; Gu, LQ; Huang, SL; Huang, ZS; Li, D; Mai, YW; Ou, TM; Tan, JH; Wang, HG; Xie, HT; Yao, BL; Yao, PF | 1 |
| Amrutkar, S; Banerjee, UC; Guchhait, SK; Kundu, CN; Nayak, A; Priyadarshani, G | 1 |
| Chen, HX; Dong, CZ; Du, ZY; Huang, ZS; Jiang, H; Li, PH; Li, YL; Tang, YD; Zhang, LY; Zhang, WJ; Zhao, MC; Zhou, W | 1 |
| Chen, HX; Dong, CZ; Du, ZY; Jiang, H; Li, PH; Wang, J; Zhang, K; Zhang, WJ | 1 |
| Chen, H; Dong, C; Du, Z; Jiang, H; Li, P; Li, Y; Zhang, K; Zhang, W | 1 |
| An, LK; Hao, XJ; Jin, LY; Khan, A; Liu, H; Liu, HY; Qin, XJ; Yan, H; Yu, Q | 1 |
12 other study(ies) available for ethidium bromide and etoposide
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Design and synthesis of a novel series of pyranonaphthoquinones as topoisomerase II catalytic inhibitors.
Topics: Aldehydes; Antigens, Neoplasm; Catalysis; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Superhelical; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Naphthoquinones; Protein Binding; Pyrans; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2008 |
New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.
Topics: Antineoplastic Agents, Phytogenic; Biological Products; Cell Line, Tumor; Drug Screening Assays, Antitumor; Evodia; Humans; Quinazolines; Structure-Activity Relationship | 2012 |
Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents.
Topics: Antineoplastic Agents; DNA Topoisomerases, Type II; Humans; Indoles; Models, Molecular; Neoplasms; Topoisomerase II Inhibitors | 2013 |
A novel p-terphenyl derivative inducing cell-cycle arrest and apoptosis in MDA-MB-435 cells through topoisomerase inhibition.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Humans; Inhibitory Concentration 50; Molecular Structure; Terphenyl Compounds; Topoisomerase Inhibitors | 2013 |
3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Biocatalysis; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Structure-Activity Relationship; Topoisomerase II Inhibitors; Xanthones | 2013 |
Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
Topics: Amines; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; HL-60 Cells; Humans; K562 Cells; Molecular Structure; Phenazines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2015 |
Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Design; Flavonoids; Humans; Neoplasm Invasiveness; Pyrimidinones; Topoisomerase II Inhibitors | 2016 |
Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers.
Topics: Antineoplastic Agents; Apoptosis; Biocatalysis; Carbazoles; Cell Cycle Checkpoints; Cell Proliferation; Chalcone; DNA Cleavage; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Molecular Structure; Plasmids; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2018 |
Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Carbazoles; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Etoposide; Humans; Intercalating Agents; Rhodanine; Topoisomerase II Inhibitors | 2018 |
Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.
Topics: | 2018 |
Eucalypglobulusals A-J, Formyl-Phloroglucinol-Terpene Meroterpenoids from Eucalyptus globulus Fruits.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; DNA Topoisomerases, Type I; Drug Screening Assays, Antitumor; Eucalyptus; Fruit; Humans; Molecular Structure; Terpenes; Topoisomerase I Inhibitors | 2018 |